Breakthrough in Targeting Pancreatic Cancer's Genetic Circuit
Researchers have identified a molecular circuit involving SRSF1, AURKA, and MYC that drives aggressive pancreatic cancer. They developed an antisense oligonucleotide that disrupts this circuit, causing cancer cells to die, which could lead to new treatments for pancreatic cancer in the future.